The French Agency for fight against doping (AFLD) returned Thursday to a “secret investigation” by refusing to say whether it had sent samples to U.S. investigators on rider Cyclist Lance Armstrong dating back to the 1999 Tour de France.
These samples of Armstrong contained the banned substance EPO, a product that is prohibited, according to a report published by the newspaper L’Equipe in 2005.
The seven-time Tour de France (1999-2005), who was accused of doping by former teammate Floyd Landis, is currently the subject of a
investigation conducted by two U.S. attorneys and the Anti-Doping Agency American (USADA).
Bruno Genevois, president of the AFLD, said the position of the French agency is to “provide assistance to judicial authorities in the
U.S. within the framework of mutual legal assistance treaties, “and tracking procedure involving different bodies (ministries Foreign Affairs and Justice, prosecutors, judicial police).
“The first contact took place (with the U.S. authorities) about an element of commission. The statement continues, “has only
added the president of the AFLD during a press briefing held at the Paris visit of the President of the World Anti-Doping Agency (WADA) John Fahey its Director General David Howman, and its chief financial officer and Legal Olivier Niggli.